T2	Pharmacological_substance 51 59	dextrose
N1000 	Reference T2 MeSH:D005947	dextrose
T3	Disorder 90 96	asthma
N1 	Reference T3 UMLS:C0004096	asthma
T6	Disorder 112 147	insulin-dependent diabetes mellitus
N2 	Reference T6 UMLS:C0011854	insulin-dependent diabetes mellitus
T8	Pharmacological_substance 240 248	dextrose
N1001 	Reference T8 MeSH:D005947	dextrose
T9	Pharmacological_substance 395 403	dextrose
N1002 	Reference T9 MeSH:D005947	dextrose
T10	Disorder 696 704	diabetic
N3 	Reference T10 UMLS:C0011860	diabetic
N4 	Reference T10 UMLS:C0011849	diabetic
T11	Disorder 723 740	diabetic-allergic
T12	Disorder 788 801	hypoglycaemia
N5 	Reference T12 UMLS:C0020615	hypoglycaemia
T14	Pharmacological_substance 823 831	dextrose
N1003 	Reference T14 MeSH:D005947	dextrose
T15	Disorder 886 894	diabetic
N6 	Reference T15 UMLS:C0011860	diabetic
N7 	Reference T15 UMLS:C0011849	diabetic
T16	Pharmacological_substance 948 982	beta-adrenoreceptor blocking drugs
N1004 	Reference T16 MeSH:D000319	beta-adrenoreceptor blocking drugs
N1005 	Reference T16 MeSH:D000319	beta-adrenoreceptor blocking drugs
N1006 	Reference T16 MeSH:D000319	beta-adrenoreceptor blocking drugs
T1	Disorder 9 31	Anaphylactoid reaction
N8 	Reference T1 UMLS:C0340865	Anaphylactoid reaction
T4	Disorder 161 183	anaphylactoid reaction
N9 	Reference T4 UMLS:C0340865	anaphylactoid reaction
T18	Pharmacological_substance 591 599	dextrose
N1007 	Reference T18 MeSH:D005947	dextrose
T20	Pharmacological_substance 284 292	dextrose
N1008 	Reference T20 MeSH:D005947	dextrose
T23	Subject 742 753	individuals
T25	Subject 895 906	individuals
T27	Subject 62 74	Two patients
T22	Subject 742 753	individuals
T29	Subject 895 906	individuals
T30	Disorder 922 930	allergic
N10 	Reference T30 UMLS:C0020517	allergic
T33	Disorder 345 353	reaction
T17	Speculation_cue 853 876	significant risk factor
